BindingDB logo
myBDB logout

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27584694 103 Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.EBI Icahn School of Medicine at Mount Sinai
26824386 41 Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.EBI University of Toronto
25406853 72 Selective inhibitors of protein methyltransferases.EBI Icahn School of Medicine at Mount Sinai
25032507 43 Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI University of North Carolina at Chapel Hill
23433670 15 Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.EBI EntreMed Inc.
23445220 50 Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.EBI University of North Carolina at Chapel Hill
22749641 15 Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.EBI Georgia State University
18619839 25 Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1).EBI Bristol-Myers Squibb Pharmaceutical Research and Development
21780790 65 Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI University of North Carolina at Chapel Hill
20666457 40 Discovery and mechanistic study of a class of protein arginine methylation inhibitors.EBI Georgia State University
20614940 76 Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.EBI University of North Carolina at Chapel Hill
19632837 15 Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.EBI Bristol-Myers Squibb Pharmaceutical Research and Development
19419866 24 Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1).EBI Bristol-Myers Squibb Pharmaceutical Research and Development
28135235 71 An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.BDB Novartis Institutes for BioMedical Research
27714957 18 Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.BDB Sichuan University
26598975 16 A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.BDB University of Toronto